Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-02-21

Clinical Trial Update: Effect of Melatonin on Schizophrenic Symptoms: a Randomized Placebo-Controlled Trial [NA]

View source ↗

Summary

A randomized placebo-controlled trial is evaluating whether melatonin can improve schizophrenic symptoms in patients with schizophrenia or related psychotic dis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Melatonin (melatonin)

Snippet

Sponsor: Lahore General Hospital | Conditions: Schizophrenia Disorders, Psychotic Disorder | NA | Status: ACTIVE_NOT_RECRUITING